Skip to main content
Equibles

JPMORGAN CHASE & CO

Position in ZNTL — Zentalis Pharmaceuticals, Inc.

CIK 19617 NEW YORK, NY
Back to ZNTL Full portfolio

Position in ZNTL

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$108,829
-$155,885 QoQ
Shares Held
22,439
-80.2% QoQ
Ownership
0.031%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#74
of 114 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority Sole 8% Shared 0% None 92%

Common Shares in ZNTL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

JPMORGAN CHASE & CO holds $12,940,196,194 across 425 Biotechnology names. ZNTL ranks #266 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 6,517,600 $3,237,487,438
2 REGN
Regeneron Pharmaceuticals, Inc.
 3,774,199 $2,353,364,036
3 INSM
INSMED Inc
 10,428,170 $1,111,851,478
4 ALNY
Alnylam Pharmaceuticals, Inc.
 2,675,517 $805,410,876
5 RVMD
Revolution Medicines, Inc.
 3,298,066 $617,661,794
6 RYTM
Rhythm Pharmaceuticals, Inc.
 2,652,746 $294,534,385
7 JAZZ
Jazz Pharmaceuticals plc
 1,160,786 $279,714,596
8 QURE
uniQure N.V.
 4,867,755 $224,208,791

All Filings in ZNTL

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $108,829 22,439
2026-03-31 $264,714 113,126
2025-12-31 $249,759 185,007
2025-09-30 $1,091,842 723,075
2025-06-30 $638,518 550,447
2025-03-31 $1,186,894 746,476
2024-12-31 $2,604,918 859,710
2024-09-30 $1,800,251 489,199
2024-06-30 $2,027,862 495,810
2024-03-31 $923,865 58,621
2023-12-31 $1,415,736 93,448
2023-09-30 $2,044,695 101,929
2023-06-30 $3,122,649 110,693
2023-03-31 $1,042,336 60,601
2022-12-31 $943,276 46,836
2022-09-30 $916,001 42,290
2022-06-30 $1,593,269 56,700
2022-03-31 $4,871,413 105,579
2021-12-31 $2,309,715 27,477
2021-09-30 $1,669,797 25,057
2021-06-30 $1,004,203 18,876
2021-03-31 $606,939 13,988
2020-12-31 $700,670 13,490
2020-09-30 $140,468 4,297
2020-06-30 $166,965 3,477